Complementation of coenzyme Q-deficient yeast by coenzyme Q analogues requires the isoprenoid side chain

FEBS Journal

Volumn 277, Issue 9, 2010, Pages 2067-2082

  James, Andrew M ^a   Cochemé, Helena M ^a,b   Murai, Masatoshi ^c   Miyoshi, Hideto ^c   Murphy, Michael P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Coenzyme Q; Diauxic shift; Mitochondria; Ubiquinone; Yeast

Indexed keywords

ALKANE; CARBON; DECYL Q; GLYCEROL; ISOPRENOID; UBIQUINONE; UBIQUINONE 2; UBIQUINONE 6; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS GROWTH; GENE IDENTIFICATION; GENETIC COMPLEMENTATION; HYDROPHOBICITY; INTRACELLULAR TRANSPORT; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION REDUCTION STATE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; RESPIRATORY CHAIN; STRUCTURE ANALYSIS; YEAST CELL;

BIOLOGICAL TRANSPORT; MICROBIAL VIABILITY; MITOCHONDRIA; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; SACCHAROMYCES CEREVISIAE; TERPENES; UBIQUINONE;

EID: 77951233551     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07622.x     Document Type: Article

References (21)

1. Tran UC Clarke CF (2007) Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion 7 (Suppl S62 S71.
2. James AM, Smith RA Murphy MP (2004) Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch Biochem Biophys 423, 47 56.
3. Muller T, Buttner T, Gholipour AF Kuhn W (2003) Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett 341, 201 204. (Pubitemid 36403763)
4. Meier T Buyse G (2009) Idebenone: an emerging therapy for Friedreich ataxia. J Neurol 256 (Suppl 1 25 30.
5. Schulz JB, Di Prospero NA Fischbeck K (2009) Clinical experience with high-dose idebenone in Friedreich ataxia. J Neurol 256 (Suppl 1 42 45.
6. James AM, Cocheme HM, Smith RA Murphy MP (2005) Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem 280, 21295 21312.
7. Sakamoto K, Miyoshi H, Takegami K, Mogi T, Anraku Y Iwamura H (1996) Probing substrate binding site of the Escherichia coli quinol oxidases using synthetic ubiquinol analogues. J Biol Chem 271, 29897 29902. (Pubitemid 26389624)
8. Sakamoto K, Miyoshi H, Ohshima M, Kuwabara K, Kano K, Akagi T, Mogi T Iwamura H (1998) Role of the isoprenyl tail of ubiquinone in reaction with respiratory enzymes: studies with bovine heart mitochondrial complex I and Escherichia coli bo-type ubiquinol oxidase. Biochemistry 37, 15106 15113. (Pubitemid 28503238)
9. 1 complex stability in yeast coq mutants. J Biol Chem 277, 10973 10981. (Pubitemid 34952853)
10. Rich PR Harper R (1990) Partition coefficients of quinones and hydroquinones and their relation to biochemical reactivity. FEBS Lett 269, 139 144. (Pubitemid 20245337)
11. Padilla-Lopez S, Jimenez-Hidalgo M, Martin-Montalvo A, Clarke CF, Navas P Santos-Ocana C (2009) Genetic evidence for the requirement of the endocytic pathway in the uptake of coenzyme Q6 in Saccharomyces cerevisiae. Biochim Biophys Acta 1788, 1238 1248.
12. James AM, Sharpley MS, Manas AR, Frerman FE, Hirst J, Smith RA Murphy MP (2007) Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem 282, 14708 14718. (Pubitemid 47093346)
13. Jungwirth H Kuchler K (2006) Yeast ABC transporters - a tale of sex, stress, drugs and aging. FEBS Lett 580, 1131 1138. (Pubitemid 43185293)
14. Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, Page N, Robinson M, Raghibizadeh S, Hogue CW, Bussey H et al. (2001) Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294, 2364 2368. (Pubitemid 33140562)
15. Queralt E Uhlmann F (2008) Separase cooperates with Zds1 and Zds2 to activate Cdc14 phosphatase in early anaphase. J Cell Biol 182, 873 883.
16. Kitagaki H, Cowart LA, Matmati N, Montefusco D, Gandy J, de Avalos SV, Novgorodov SA, Zheng J, Obeid LM Hannun YA (2009) ISC1-dependent metabolic adaptation reveals an indispensable role for mitochondria in induction of nuclear genes during the diauxic shift in Saccharomyces cerevisiae. J Biol Chem 284, 10818 10830.
17. Matmati N Hannun YA (2008) Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases. J Lipid Res 49, 922 928.
18. Arenz C, Thutewohl M, Block O, Waldmann H, Altenbach HJ Giannis A (2001) Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase. Chembiochem 2, 141 143. (Pubitemid 33722539)
19. Martin SF, Gomez-Diaz C, Navas P Villalba JM (2002) Ubiquinol inhibition of neutral sphingomyelinase in liver plasma membrane: specific inhibition of the Mg(2+)-dependent enzyme and role of isoprenoid chain. Biochem Biophys Res Commun 297, 581 586.
20. Hsu AY, Do TQ, Lee PT Clarke CF (2000) Genetic evidence for a multi-subunit complex in the O-methyltransferase steps of coenzyme Q biosynthesis. Biochim Biophys Acta 1484, 287 297.
21. Gietz RD Woods RA (2002) Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. Methods Enzymol 350, 87 96.